Deborah Stoll, A MM&M Digital Publication
Drew Gutschmidt, President, Policy Reporter, a TrialCard company
Scott Dulitz, Chief Strategy Officer, TrialCard

Before going to market with a new drug, medical device, or test, it’s crucial to know how payers will treat it post-approval. Understanding post-launch coverage restrictions and knowing which payers are likely to publish policy in the first six months to two years allows organizations to design effective marketing strategies. Enter Bumblebee, a patented software system that tracks public domain payer policies that are either new or new versions of existing documents.